Revolutions Medical has finalized a manufacturing agreement with Medical Investment Group (MIG), pursuant to which MIG has guaranteed the production and delivery of a minimum of five million 3cc safety syringes per month for a period of five years.
MIG’s manufacturing facility is a 250,000 square foot factory located on 35 acres in Jiangsu, China, and is fully compliant with all FDA and CE/EC requirements and has experience producing and shipping similar medical products for worldwide delivery.
Revolutions Medical CEO Ron Wheet said that securing this first manufacturing relationship and having the ability to produce and ship a minimum of five million safety syringes per month beginning in the first quarter of 2011, they are in a position to sign initial distributors and begin to gauge preliminary sale volumes.
“The facility has the ability to increase production up to 50 million 3cc syringes per month. When we initiate the manufacturing process on our 1cc, 5cc, and 10cc RevVac safety syringes, we will plan to produce those in South Carolina,” Wheet said.